Acute, adverse skin effects to capsaicin can be activated by inhibition of sodium transport not only in nociceptive neurons, but also in keratinocytes. The aim of the current study was to describe and compare immediate (15 s) and prolonged (30 min) effects of capsaicin on epidermal (not neural) sodium transport using a rabbit skin model. Skin fragments (n = 169) were incubated in 4 conditions: undisturbed ion transport (U; n = 48); inhibited sodium transport (INa; n = 34) with amiloride used as sodium transport blocker; long-term irritation by capsaicin with undisturbed ion transport (CAPSA-U; n = 43) and with inhibited sodium transport (CAPSA-INa; n = 35). After 30 min of incubation, a solution of capsaicin was applied directly to the skin fragments. The study demonstrated that sodium transport inhibition eliminated the effects of both immediate and prolonged capsaicin application. The results could be the basis for future research considering selective sodium transport inhibitors for human skin to reduce the side effects of capsaicin, related to activation of sodium channels in keratinocytes.

Keywords:
Epithelial sodium channel, Keratinocytes, Amiloride, Transepithelial potential difference, Transepithelial electrical resistance
1.
Jara-Oseguera A, Simon SA, Rosenbaum T: TRPV1: on the road to pain relief. Curr Mol Pharmacol 2008;1:255-269.
2.
Szallasi A, Sheta M: Targeting TRPV1 for pain relief: limits, losers and laurels. Expert Opin Investig Drugs 2012;21:1351-1369.
3.
Backonja M, Wallace MS, Blonsky ER, Cutler BJ, Malan P Jr, Rauck R, et al: NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study. Lancet Neurol 2008;7:1106-1112.
4.
Haanpaa M, Treede RD: Capsaicin for neuropathic pain: linking traditional medicine and molecular biology. Eur Neurol 2012;68:264-275.
5.
Sharma SK, Vij AS, Sharma M: Mechanisms and clinical uses of capsaicin. Eur J Pharmacol 2013;720:55-62.
6.
Knotkova H, Pappagallo M, Szallasi A: Capsaicin (TRPV1 agonist) therapy for pain relief: farewell or revival? Clin J Pain 2008;24:142-154.
7.
Wong GY, Gavva NR: Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: recent advances and setbacks. Brain Res Rev 2009;60:267-277.
8.
Mason L, Moore RA, Derry S, Edwards JE, McQuay HJ: Systematic review of topical capsaicin for the treatment of chronic pain. BMJ 2004;328:991.
9.
Smith H, Brooks JR: Capsaicin-based therapies for pain control. Prog Drug Res 2014;68:129-146.
10.
Derry S, Rice ASC, Cole P, Tan T, Moore R: Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Cochrane Database Syst Rev 2017;1:CD007393.
11.
Wolkerstorfer A, Handler N, Buschmann H: New approaches to treating pain. Bioorg Med Chem Lett 2016;26:1103-1119.
12.
Kiani J, Sajedi F, Nashrollahi S, Esna-Ashari F: A randomized clinical trial of efficacy and safety of the topical clonidine and capsaicin in the treatment of painful diabetic neuropathy. J Res Med Sci 2015;20:359-363.
13.
Wang S, Joseph J, Ro JY, Chung MK: Modality-specific mechanisms of protein kinase C-induced hypersensitivity of TRPV1:S800 is a polymodal sensitization site. Pain 2015;156:931-941.
14.
Chen CL, Li H, Xing XH, Guan HS, Zhang JH, Zhao JW: Effect of TRPV1 gene mutation on bronchial asthma in children before and after treatment. Allergy Asthma Proc 2015;36:e29-e36.
15.
Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D: The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997;389:816-824.
16.
Ross RA: Anandamide and vanilloid TRPV1 receptors. Br J Pharmacol 2003;140:790-801.
17.
Chavez AE, Chiu CQ, Castillo PE: TRPV1 activation by endogenous anandamide triggers postsynaptic long-term depression in dentate gyrus. Nat Neurosci 2010;13:1511-1518.
18.
Caterina MJ, Julius D: The vanilloid receptor: a molecular gateway to the pain pathway. Annu Rev Neurosci 2001;24:487-517.
19.
O'Neill J, Brock C, Olesen AE, Andresen T, Nilsson M, Dickenson AH: Unravelling the mystery of capsaicin: a tool to understand and treat pain. Pharmacol Rev 2012;64:939-971.
20.
Liu L, Simon SA: Capsaicin-induced currents with distinct desensitization and Ca2+ dependence in rat trigeminal ganglion cells. J Neurophysiol 1996;75:1503-1514.
21.
Su X, Wachtel RE, Gebhart GF: Capsaicin sensitivity and voltage-gated sodium currents in colon sensory neurons from rat dorsal root ganglia. Am J Physiol 1999;277(6 Pt 1):G1180-G1188.
22.
Liu L, Oortgiesen M, Li L, Simon SA: Capsaicin inhibits activation of voltage-gated sodium currents in capsaicin-sensitive trigeminal ganglion neurons. J Neurophysiol 2001;85:745.
23.
Onizuka S, Yonaha T, Tamura R, Hosokawa N, Kawasaki Y, Kashiwada M, et al: Capsaicin indirectly suppresses voltage-gated Na+ currents through TRPV1 in rat dorsal root ganglion neurons. Anesth Analg 2011;112:703-709.
24.
Kennedy WR, Vanhove GF, Lu SP, Tobias J, Bley KR, Walk D, et al: A randomized, controlled, open-label study of the long-term effects of NGX-4010, a high-concentration capsaicin patch, on epidermal nerve fiber density and sensory function in healthy volunteers. J Pain 2010;11:579-587.
25.
Anand P, Bley K: Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch. Br J Anaesth 2011;107:490-450.
26.
Brown S, Simpson DM, Moyle G, Brew BJ, Schifitto G, Larbalestier N, et al: NGX-4010, a capsaicin 8% patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: integrated analysis of two phase III, randomized, controlled trials. AIDS Res Ther 2013;10:5.
27.
Mou J, Paillard F, Turnbull B, Trudeau J, Stoker M, Katz NP: Efficacy of Qutenza® (capsaicin) 8% patch for neuropathic pain: a meta-analysis of the Qutenza Clinical Trials Database. Pain 2013;154:1632-1639.
28.
Szolcsanyi J: Capsaicin and sensory neurones: a historical perspective. Prog Drug Res 2014;68:1-37.
29.
Peppin JF, Pappagallo M: Capsaicinoids in the treatment of neuropathic pain: a review. Ther Adv Neurol Disord 2014;7:22-32.
30.
Derry S, Sven-Rice A, Cole P, Tan T, Moore RA: Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Cochrane Database Syst Rev 2013;2:CD007393.
31.
Ma X-L, Zhang F-X, Dong F, Bao L, Zhang X: Experimental evidence for alleviating nociceptive hypersensitivity by single application of capsaicin. Mol Pain 2015;11:22.
32.
Caterina MJ, Leffler A, Malmberg AB, Martin WJ, Trafton J, Petersen-Zeitz KR, Koltzenburg M, Basbaum AI, Julius D: Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 2000;288:306-313.
33.
Yan JY, Sun RQ, Hughes MG, McAdoo DJ, Willis WD: Intradermal injection of capsaicin induces acute substance P release from rat spinal cord dorsal horn. Neurosci Lett 2006;410:183-186.
34.
Baumbauer KM, DeBerry JJ, Adelman PC, Miller RH, Hachisuka J, Lee KH, Ross SE, Koerber HR, Koerber R, Davis BM, Albers KM: Keratinocytes can modulate and directly initiate nociceptive responses. Elife 2015;4:e09674.
35.
Pang Z, Sakamoto T, Tiwari V, Kim YS, Yang F, Dong X, Guler AD, Guan Y, Caterina MJ: Selective keratinocyte stimulation is sufficient to evoke nociception in mice. Pain 2015;156:656-665.
36.
Mauro T, Behne M, Oda Y, et al: The ENaC channel is required for normal epidermal differentiation. J Investig Dermatol 2002;118:589-594.
37.
Hill WG, Butterworth MB, Wang H, et al: The epithelial sodium channel (ENaC) traffics to apical membrane in lipid rafts in mouse cortical collecting duct cells. J Biol Chem 2007;282:37402-37401.
38.
Xu W, Hong SJ, Zeitchek M, et al: Hydration status regulates sodium flux and inflammatory pathways through epithelial sodium channel (ENaC) in the skin. J Investig Dermatol 2015;135:796-806.
39.
Ferreira D, Silva C, Souza M: Electrical impedance model for evaluation of skin irritation in rabbits and humans. Skin Res Technol 2007;13:259-267.
40.
Jung EC, Maibach H: Animal models for percutaneous absorption. J Appl Toxicol 2015;35:1-10.
41.
Nicoli S, Padula C, Aversa V, Vietti B, Wertz PW, Millet A, Falson F, Govoni P, Santi P: Characterization of rabbit ear skin as a skin model for in vitro transdermal permeation experiments: histology, lipid composition and permeability. Skin Pharmacol Physiol 2008;21:218-226.
42.
Rittié L: Cellular mechanisms of skin repair in humans and other animals. J Cell Commun Signal 2016;10:103-120.
43.
Raj N, Voegeli R, Rawlings AV, Doppler S, Imfeld D, Munday MR, Lane ME: A fundamental investigation into aspects of the physiology and biochemistry of the stratum corneum in subjects with sensitive skin. Int J Cosmet Sci 2017;39:2-10.
44.
Weyer AD, Zappia KJ, Garrison SR, Ohara CL, Dodge AK, Stucky CL: Nociceptor sensitization depends on age and pain chronicity. eNeuro 2016;3:0115-15.2015.
45.
Thinschmidt J, King M, Korab M, Perez P, Febo M, Miyan J, Grant M: Central neural activation following contact sensitivity peripheral immune challenge: evidence of brain-immune regulation through C fibres. Immunology 2015;146:206-216.
46.
Chen Y, Fang Q, Wang Z, Zhang J, MacLeod A, Hall R, Liedtke W: Transient receptor potential vanilloid 4 ion channel functions as a pruriceptor in epidermal keratinocytes to evoked histaminergic itch. J Biol Chem 2016;291:10252-10262.
47.
Zegarska B, Lelińska A, Tyrakowski T: Investigation of environmental physical factors on epithelium of isolated frog skin in model system. Med Biol Sci 2005;194:195-200.
48.
Yang H, Charles R-P, Hummler E, Baines DL, Isseroft RR: The epithelial sodium channel mediates the directionality of galvanotaxis in human keratinocytes. J Cell Sci 2013;136:1942-1961.
49.
Liu Z, Hu Y, Yu X, Xi J, Fan X, Tse C-M, Myers AC, Pasricha PJ, Li X, Yu S: Allergen challenge sensitizes TRPA1 in vagal sensory neurons and afferent C-fibre subtypes in guinea pig esophagus. Am J Physiol Gastrointest Liver Physiol 2015;308:G482-G488.
50.
De Silva Serra I, Husson Z, Bartlett J, Smith E: Characterization of cutaneous and articular sensory neurons. Mol Pain 2016;12:1-14.
51.
Murakami S, Sudo Y, Myano K, Nishimura H, Matoba M, Shirashi S, Konno H, Uezono Y: Tris-hydroxymethyl-aminomethane enhances capsaicin-induced intracellular Ca2+ influx transient receptor potential V1 (TRPV1) channel. J Pharmacol Sci 2016;130:72-77.
52.
Eisenhut M, Wallace H: Ion channels in inflammation. Eur J Physiol 2011;461:401-421.
53.
Takada H, Furuya K, Sokabe M: Mechanosensitive ATP release from hemichannels and Ca2+ influx through TRPC6 accelerate wound closure in keratinocytes. J Cell Sci 2014;127:4159-4171.
54.
Murakami S, Sudo Y, Myano K, Nishimura H, Matoba M, Shirashi S, Konno H, Uezono Y: Tris-hydroxymethyl-aminomethane enhances capsaicin-induced intracellular Ca2+ influx transient receptor potential V1 (TRPV1) channel. J Pharmacol Sci 2016;130:72-77.
55.
Faske S, Wulff H, Skolnik E: Ion channels in innate and adaptive immunity. Annu Rev Immunol 2015;33:291-353.
56.
Duangjit S, Chairat W, Opanasopit P, Rojanarata T, Panomsuk S, Ngawhirunpat T: Development, characterization and skin interaction of capsaicin-loaded microemulsion-based nonionic surfactant. Biol Pharm Bull 2016;39:601-610.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.